Literature DB >> 6259259

Plasminogen activator is an apparent lymphocyte mitogen.

S D Cohen, E Israel, B Spiess-Meier, M A Wainberg.   

Abstract

Culture fluids of avian sarcoma virus (ASV)-transformed but not normal chicken embryo cells frequently elicited a mitogenic response in normal avian and murine lymphocytes. We examined the possibility that plasminogen activator (PA) might be responsible for the observed mitogenic effect. PA activity, present in culture medium, was correlated positively with lymphocyte mitogenic capacity. Treatment of cells with phorbol myristate acetate, which elevates PA levels, increased mitogenesis. Similar treatment with dexamethasone, which inhibits PA biosynthesis and/or secretion, reduced lymphocyte mitogenic activity. Addition to culture fluids of either benzamidine or diisopropylfluorophosphate, both specific PA inhibitors, blocked lymphocyte proliferative responsiveness to culture fluids. In contrast, neither epsilon-amino-caproic acid nor trasylol, which inhibits plasmin esterase activity but not PA, abrogated lymphocyte responsiveness. Furthermore, purified urokinase, an enzyme of similar substrate specificity to PA, had lymphocyte stimulatory activity. These results strongly suggest that PA can function as a lymphocyte mitogen.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6259259

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes.

Authors:  M P Stoppelli; A Corti; A Soffientini; G Cassani; F Blasi; R K Assoian
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

2.  Further studies on the mitogenic and immune-modulating effects of plasminogen activator.

Authors:  M A Wainberg; E Israel; R G Margolese
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

3.  Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA.

Authors:  P Verde; M P Stoppelli; P Galeffi; P Di Nocera; F Blasi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

4.  Alpha-1 anti-trypsin and CD30 expression occur in parallel in activated T cells.

Authors:  M S Bashir; D B Jones; D H Wright
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

5.  Modulation of urokinase plasminogen activator gene expression during the transition from quiescent to proliferative state in normal mouse cells.

Authors:  G Grimaldi; P Di Fiore; E K Locatelli; J Falco; F Blasi
Journal:  EMBO J       Date:  1986-05       Impact factor: 11.598

6.  PLAU inferred from a correlation network is critical for suppressor function of regulatory T cells.

Authors:  Feng He; Hairong Chen; Michael Probst-Kepper; Robert Geffers; Serge Eifes; Antonio Del Sol; Klaus Schughart; An-Ping Zeng; Rudi Balling
Journal:  Mol Syst Biol       Date:  2012       Impact factor: 11.429

7.  The plasminogen activator system: involvement in central nervous system inflammation and a potential site for therapeutic intervention.

Authors:  Devorah Gur-Wahnon; Tehila Mizrachi; Florence-Yehudith Maaravi-Pinto; Athanasis Lourbopoulos; Nikolaos Grigoriadis; Abd-Al Roof Higazi; Talma Brenner
Journal:  J Neuroinflammation       Date:  2013-10-11       Impact factor: 8.322

8.  Longitudinal Assessment of Cytokine Expression and Plasminogen Activation in Hantavirus Cardiopulmonary Syndrome Reveals Immune Regulatory Dysfunction in End-Stage Disease.

Authors:  Peter Simons; Yan Guo; Virginie Bondu; Susan L Tigert; Michelle Harkins; Samuel Goodfellow; Cana Tompkins; Devon Chabot-Richards; Xuexian O Yang; Laura Gonzalez Bosc; Steven Bradfute; Daniel A Lawrence; Tione Buranda
Journal:  Viruses       Date:  2021-08-12       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.